Migdal Insurance & Financial Holdings Ltd. - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 66 filers reported holding UROGEN PHARMA LTD in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Migdal Insurance & Financial Holdings Ltd. ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$9,083
+25.7%
648,302
-7.2%
0.19%
+16.2%
Q2 2023$7,227
+12.0%
698,3020.0%0.17%
+16.8%
Q1 2023$6,452
+4.2%
698,3020.0%0.14%
+3.6%
Q4 2022$6,194
-99.9%
698,3020.0%0.14%
+5.3%
Q3 2022$5,810,000
+1.6%
698,3020.0%0.13%
+3.1%
Q2 2022$5,719,000
-6.0%
698,3020.0%0.13%
+19.8%
Q1 2022$6,082,000
-8.4%
698,3020.0%0.11%
+65.6%
Q4 2021$6,641,000
-43.5%
698,3020.0%0.06%
-48.4%
Q3 2021$11,745,000
+10.1%
698,3020.0%0.12%
+10.7%
Q2 2021$10,663,000
-21.6%
698,3020.0%0.11%
-18.2%
Q1 2021$13,603,000
+2.2%
698,302
-5.4%
0.14%
-12.7%
Q4 2020$13,304,000
-6.6%
738,3020.0%0.16%
-20.7%
Q3 2020$14,242,000
-26.1%
738,3020.0%0.20%
-36.7%
Q2 2020$19,284,000
+46.4%
738,3020.0%0.31%
+2.3%
Q1 2020$13,171,000
-46.5%
738,3020.0%0.31%
-35.6%
Q4 2019$24,637,000
+33.7%
738,302
-4.5%
0.48%
+24.3%
Q3 2019$18,428,000
+45.1%
773,302
+118.9%
0.38%
+17.5%
Q2 2019$12,698,000
-2.7%
353,3020.0%0.32%
+4.2%
Q1 2019$13,051,000353,3020.31%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders